Home > Research > Publications & Outputs > Genomics implicates adaptive and innate immunit...

Electronic data

  • NeurodegenPaper-PURE

    Accepted author manuscript, 680 KB, PDF document

    Available under license: CC BY-NC-ND: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License


Text available via DOI:

View graph of relations

Genomics implicates adaptive and innate immunity in Alzheimer’s and Parkinson’s diseases

Research output: Contribution to Journal/MagazineJournal articlepeer-review

  • Sarah A. Gagliano
  • Jennie G. Pouget
  • John Hardy
  • Jo Knight
  • Michael R. Barnes
  • Mina Ryten
  • Mike Weale
<mark>Journal publication date</mark>12/2016
<mark>Journal</mark>Annals of Clinical and Translational Neurology
Issue number12
Number of pages10
Pages (from-to)924-933
Publication StatusPublished
Early online date4/11/16
<mark>Original language</mark>English


We assessed the current genetic evidence for the involvement of various cell types and tissue types in the aetiology of neurodegenerative diseases, especially in relation to the neuroinflammatory hypothesis of neurodegenerative diseases.

We obtained large-scale genome-wide association study (GWAS) summary statistics from Parkinson’s disease (PD), Alzheimer’s disease (AD), and amyotrophic lateral sclerosis (ALS). We used multiple sclerosis (MS), an autoimmune disease of the central nervous system, as a positive control. We applied stratified LD score regression to determine if functional marks for cell type and tissue activity, and gene set lists were enriched for genetic heritability. We compared our results to
those from two gene-set enrichment methods (Ingenuity Pathway Analysis and enrichr).

There were no significant heritability enrichments for annotations marking genes active within brain regions, but there were for annotations marking genes active within cell-types that form part of both the innate and adaptive immune systems. We found this for MS (as expected) and also for AD and PD. The strongest signals were from the adaptive immune system (e.g. T cells) for PD, and from both the adaptive (e.g. T cells) and innate (e.g. CD14: a marker for monocytes, and CD15:
a marker for neutrophils) immune systems for AD. Annotations from the liver were also significant for AD. Pathway analysis provided complementary results.

For Alzheimer’s and Parkinson’s disease, we found significant enrichment of heritability in annotations marking gene activity in immune cells.